Tech Company Financing Transactions

Jurata Thin Film Funding Round

On 11/29/2022, Jurata Thin Film raised $4.9 million in Seed funding from Golden Seeds, Columbus Venture Partners and Ferocity Capital.

Transaction Overview

Company Name
Jurata Thin Film
Announced On
11/29/2022
Transaction Type
Venture Equity
Amount
$4,870,000
Round
Seed
Investors

Golden Seeds (Lead Investor)

Columbus Venture Partners

Ferocity Capital

private investors (Jude Samulski)

private investors (Maria Croyle)

private investors (Sheila Mikhail)

University of Texas

Proceeds Purpose
The company intends to use the funds to design and build a pilot-scale manufacturing line capable of fabricating over 1,000 doses of vaccine- or biologic-loaded thin films per hour and to support the requisite toxicity studies demonstrating safety of its formulation for administration under the tongue (sublingual), inside the cheek (buccal), or through intramuscular injection after rehydration.

Company Information

Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
870 Martin Luther King Junior Blvd.
Chapel Hill, NC 27514
USA
Phone
Undisclosed
Website
www.juratatf.com
Email Address
[email protected]
Overview
At Jurata Thin Film, our mission is to simplify the transport and storage of vaccines and biologics. Our technology will make cutting edge therapies accessible to everyone who needs them around the world. Jurata Thin Film believes that all people should have access to life saving vaccines and therapeutics, no matter where they are in the world.
Profile
Jurata Thin Film LinkedIn Company Profile
Social Media
Jurata Thin Film Company Twitter Account
Company News
Jurata Thin Film News
Facebook
Jurata Thin Film on Facebook
YouTube
Jurata Thin Film on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sheila Mikhail
  Sheila Mikhail LinkedIn Profile  Sheila Mikhail Twitter Account  Sheila Mikhail News  Sheila Mikhail on Facebook
Co-Founder
Jude Samulski
  Jude Samulski LinkedIn Profile  Jude Samulski Twitter Account  Jude Samulski News  Jude Samulski on Facebook
VP - Bus. Development
Megan Livingston
  Megan Livingston LinkedIn Profile  Megan Livingston Twitter Account  Megan Livingston News  Megan Livingston on Facebook
VP - R & D
Christopher Pavlos
  Christopher Pavlos LinkedIn Profile  Christopher Pavlos Twitter Account  Christopher Pavlos News  Christopher Pavlos on Facebook
VP - Sales
Maria Croyle
  Maria Croyle LinkedIn Profile  Maria Croyle Twitter Account  Maria Croyle News  Maria Croyle on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/29/2022: Biorelate venture capital transaction
Next: 11/29/2022: Heex Technologies venture capital transaction

 

Share this article

 

Where The Data Comes From

We record every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.